Drugs / Allogenic FMT
Allogenic FMT
Trials 1
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| Phase 2/31 trial | ||||||
| Phase 2/3 | NCT04188743 | Dec 2019 → Dec 2025 overdue | primary bacterial infectious disease | University Hospital, Ghent | Recruiting | No outcome recorded |
| Comparator or background therapy1 trial | ||||||
| Phase 2/3 | NCT03279224 Comparator | Jan 2018 → Mar 2022 | bipolar depression | Women's College Hospital | Unknown | No outcome recorded |
Evidence & citations 5 cited values
Every value below carries the sentence it was read from. 2 sources stand behind the page.
| Field | Value | Cited text |
|---|---|---|
| Known as | Allogenic FMT | ClinicalTrials.gov intervention name — accepted as the source's own label NCT03279224 ↗ |
| Known as | Fecal microbiota transplantation | “Fecal microbiota transplantation(FMT) is a technique in which gut bacteria are transferred from a healthy screened donor to a patient” NCT03279224 ↗ |
| Known as | FMT | “Fecal microbiota transplantation(FMT) is a technique in which gut bacteria are transferred from a healthy screened donor to a patient” NCT03279224 ↗ |
| Action | Restore | “with the goal to introduce or restore a stable microbial community in the gut” NCT03279224 ↗ |
| Route | Other | “For colonoscopy administration” NCT03279224 ↗ |